Arkolith/Insider Trading/RPTX/Form 4

Segal Lloyd Mitchell

PRESIDENT AND CEO, DirectorRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Apr 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$24K
Net Open-Market Flow
-$24K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Sell(S)2K$4.63$12K108K
Mar 28, 2024Sell(S)3K$4.62$12K110K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-009629) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML